-transparent.png){kind=logo}
We administer during 6 months in randomised way dihydroergotamine or flunarizine to 50 children affects of classical or common migraine. A significative improvement was estimated in frequency, intensity and duration of their crisis in 87% with dihydroergotamine and 79% with flunarizine, without significative differences from one to other. Dihydroergotamine was specially effective in children with vegetative lability. The secondary effects, 12% with dihydroergotamine and 20% with flunarizine, were trivial and advantageous even, without the necessity of stop the treatment in not any case.
Related Publications
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
January 1988,
Fortschritte der Medizin,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
November 1986,
Ceskoslovenska pediatrie,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
January 2009,
Headache,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
April 1989,
Headache,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
September 2009,
Expert opinion on drug metabolism & toxicology,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
November 1950,
Paris medical,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
May 2004,
MMW Fortschritte der Medizin,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
November 1958,
The Practitioner,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
August 1948,
Belgisch tijdschrift voor geneeskunde,
L Lastra Martínez, and
J Herranz Fernández, and
R Arteaga Manjón-Cabez
July 1988,
Annals of emergency medicine,
